Covid-19: Over 286,000 beneficiaries of age group 18-44 vaccinated on May 8

The Union Health Ministry informed that as many as 286,800 beneficiaries of the age group 18 to 44 years received their first dose of Covid-19 vaccine on Saturday.

Medics inoculate doses of COVID-19 vaccine to people during the third phase of the vaccination drive, at BKC Jumbo Covid Centre in Mumbai on Saturday. COVID-19 vaccination drive for people above 18 years has begun.
ANI General News
2 min read Last Updated : May 09 2021 | 7:26 AM IST

The Union Health Ministry informed that as many as 2,86,800 beneficiaries of the age group 18 to 44 years received their first dose of COVID-19 vaccine on Saturday.

According to the Union Health ministry, cumulatively, 17,76,540 beneficiaries aged between 18-44 years across 30 states/UTs have been vaccinated.

Cumulatively, with 3,82,405 administered doses, Maharashtra has vaccinated the most beneficiaries between the age bracket of 18 to 44 years.

The total vaccinations across the country have crossed the 16.92 crore mark. The country has administered nearly 18,93,258 vaccine doses Saturday.

The cumulative number of COVID-19 vaccine doses administered in the country stands at 16,92,98,763.

The total of 16,92,98,763 include 95,39,865 Healthcare Workers (HCWs) who have taken the 1st dose and 64,61,868 HCWs who have taken the 2nd dose, 1,39,33,627 Frontline Workers (FLWs) (1st dose), 77,21,853 FLWs (2nd dose), and 17,76,540 for 18-44 years of age group (1st dose). 5,50,47,203 for over 45 years old to 60 years old (1st Dose), 63,72,579 for over 45 years old to 60 years old (2nd dose), 5,36,24,623 for above 60 years (1st Dose) and 1,48,20,605 for above 60 years (2nd Dose).

The 'liberalized and accelerated' phase-3 strategy of Covid-19 vaccination came into force on May 1. Registration for the newly eligible population groups had commenced on April 28.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :LockdownCoronavirus VaccineCoronavirus Tests

First Published: May 09 2021 | 7:09 AM IST

Next Story